Analgesic effect of intrathecally administered matrix metalloproteinase 2 (MMP-2) in the rat formalin test

Neurosci Lett. 2003 Aug 21;347(2):77-80. doi: 10.1016/s0304-3940(03)00668-2.

Abstract

Matrix metalloproteinases (MMPs) are a family of extracellular endopeptidases that selectively degrade components of the extracellular matrix. In the present study, the authors examined the effect of intrathecal injection of MMP-2 on the nociceptive transmission during the rat formalin test (a model of inflammatory pain). The paw formalin injection induces biphasic flinching (phase 1: 0-6 min; phase 2: 10-60 min) of the injected paw. Intrathecal injection of 1 microg of MMP-2 depressed the phase 1 agitation behavior, but not the phase 2 agitation behavior, and this effect of MMP-2 was antagonized by ONO-4817, an MMP inhibitor. ONO-4817 itself had no effect on the formalin test. These data suggest that exogenously applied MMP-2 to the spinal cord produces analgesic effects in the rat formalin test.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / administration & dosage
  • Analgesics / pharmacology*
  • Animals
  • Dose-Response Relationship, Drug
  • Injections, Spinal
  • Male
  • Matrix Metalloproteinase 2 / administration & dosage
  • Matrix Metalloproteinase 2 / pharmacology*
  • Matrix Metalloproteinase 2 / physiology
  • Pain / physiopathology*
  • Pain Measurement
  • Phenyl Ethers / pharmacology
  • Protease Inhibitors / pharmacology
  • Rats
  • Rats, Sprague-Dawley

Substances

  • Analgesics
  • N-hydroxy-5-ethoxymethyloxy-2-methyl-4-(4-phenoxybenzoyl)aminopentanamide
  • Phenyl Ethers
  • Protease Inhibitors
  • Matrix Metalloproteinase 2